Brought to you by 
Cytox raises £600k in pre-Series A round
16 Jul 2009
Executive Summary
Cytox (Alzheimer's disease biomarker services) raised £600k ($1mm) in a pre-Series A financing, which was led by returning backer Midven--through its Advantage Growth Fund--and included first-time shareholder Masa Life Sciences, company management, plus an individual US angel investor who is joining the start-up as an advisor.
Deal Industry
- In Vitro Diagnostics
- Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cytox raises £600k in pre-Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice